RUTW250506P1770000
- 15.85
- 0.000.00%
Russell 2000 Index Newsroom
Tesla, Palantir, Hims & Hers, Ford, DoorDash, SolarEdge, Vertex: Biggest Movers
Earnings Call Summary | MasterBrand(MBC.US) Q1 2025 Earnings Conference
Earnings Call Summary | Purple Innovation(PRPL.US) Q1 2025 Earnings Conference
Earnings Call Summary | Viant Technology(DSP.US) Q1 2025 Earnings Conference
Earnings Call Summary | Jamf Holding(JAMF.US) Q1 2025 Earnings Conference
Earnings Call Summary | WideOpenWest(WOW.US) Q1 2025 Earnings Conference
Earnings Call Summary | NerdWallet(NRDS.US) Q1 2025 Earnings Conference
BlackLine Outlines 2025 Goals With Focus on Studio360 and SAP Partnership
WideOpenWest Targets $60M-$70M Greenfield CapEx for 2025 Amid Fiber Expansion Momentum
Earnings Call Summary | Hackett Group(HCKT.US) Q1 2025 Earnings Conference
Viant Technology Targets 19% Revenue Growth in Q2 2025 Driven by CTV Expansion
Jamf Outlines 2025 Revenue Growth Targets With New Product Expansions
The Hackett Group Projects $76M to $77.5M Q2 Revenue With Focus on Gen AI Growth
Astronics Corporation (ATRO) Q1 2025 Earnings Call Transcript Summary
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Corsair Gaming Outlines AI Integration and Fanatec Expansion Amid 10% Revenue Growth in Q1 2025
Earnings Call Summary | Upstart(UPST.US) Q1 2025 Earnings Conference
Nature's Sunshine Outlines 2025 Growth Strategy With Focus on Asia Pacific and Europe Amid Tariff Challenges
Upstart Signals Strong Q2 2025 Revenue Growth With $225M Forecast
Earnings Call Summary | Arcus Biosciences(RCUS.US) Q1 2025 Earnings Conference